James Larkin

PhD, FRCP, The Royal Marsden, US

Specializes in [Skin Cancer]

Lead author of Checkmate 067 trial of nivolumab and ipilimumab in advanced melanoma
Scientific Co-Chair ESMO 2026 meeting
Clarivate highly cited researcher for the last 5 consecutive years